mHSPC 3 CHMP建议欧盟批准达罗鲁米特加ADT用于mHSPC 2025/06/20 CHMP recommends EU approval of darolutamide plus ADT in mHSPC 2025/06/20 不同mHSPC人群中剩余未满足的需求 2025/06/16